Abstract
Motor neuron diseases (MND) are progressive neuromuscular disorders that affect lower motor neurons and sometimes, upper motor neurons. Some of the MNDs manifest early in life while some develop later. Sleep disordered breathing (SDB) is a very common association in these diseases and can present as sleep apnea or hypoventilation. Untreated, SDB contributes to morbidity and reduced quality of life. In this chapter, we discuss the different types of MNDs and then about the associated sleep issues in these disorders. Early recognition of these associated sleep disorders and appropriate therapeutic intervention is the key to improve quality of life and reduce morbidity and mortality in these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AHI:
-
Apnea hypopnea index
- ALS:
-
Amyotrophic lateral sclerosis
- LOSMoN:
-
Late onset spinal motor neuronopathy
- MA:
-
Monomelic amyotrophy
- NIV:
-
Noninvasive ventilation
- NREM:
-
Non-rapid eye movement
- OSA:
-
Obstructive sleep apnea
- PLMS:
-
Periodic leg movements in sleep
- PLS:
-
Primary lateral sclerosis
- PMA:
-
Progressive muscular atrophy
- PSG:
-
Polysomnogram
- REM:
-
Rapid eye movement
- RERA:
-
Respiratory effort-related arousals
- RLS:
-
Restless leg syndrome
- SDB:
-
Sleep disordered breathing
- SMA:
-
Spinal muscular atrophy
- SMA-LED:
-
SMA with lower extremity predominance
- SMN:
-
Survival motor neuron
- SNIP:
-
Sniff nasal inspiratory pressure
- SPSMA:
-
Scapuloperoneal SMA
References
Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831–46.
Jokela M, Penttila S, Huovinen S, Hackman P, Saukkonen AM, Toivanen J, et al. Late-onset lower motor neuronopathy: a new autosomal dominant disorder. Neurology. 2011;77(4):334–40.
Harms MB, Allred P, Gardner R Jr, Fernandes Filho JA, Florence J, Pestronk A, et al. Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32. Neurology. 2010;75(6):539–46.
Rudnik-Schoneborn S, Deden F, Eggermann K, Eggermann T, Wieczorek D, Sellhaus B, et al. Autosomal dominant spinal muscular atrophy with lower extremity predominance: a recognizable phenotype of BICD2 mutations. Muscle Nerve. 2016;54(3):496–500.
Tsurusaki Y, Saitoh S, Tomizawa K, Sudo A, Asahina N, Shiraishi H, et al. A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics. 2012;13(4):327–32.
Niu Q, Wang X, Shi M, Jin Q. A novel DYNC1H1 mutation causing spinal muscular atrophy with lower extremity predominance. Neurol Genet. 2015;1(2):e20.
La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77–9.
Finsterer J. Bulbar and spinal muscular atrophy (Kennedy’s disease): a review. Eur J Neurol. 2009;16(5):556–61.
Goldenberg JN, Bradley WG. Testosterone therapy and the pathogenesis of Kennedy’s disease (X-linked bulbospinal muscular atrophy). J Neurol Sci. 1996;135(2):158–61.
Finsterer J, Soraru G. Onset manifestations of spinal and bulbar muscular atrophy (Kennedy’s disease). J Mol Neurosci. 2016;58(3):321–9.
Statland JM, Barohn RJ, McVey AL, Katz JS, Dimachkie MM. Patterns of weakness, classification of motor neuron disease, and clinical diagnosis of sporadic amyotrophic lateral sclerosis. Neurol Clin. 2015;33(4):735–48.
Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–93.
Al-Chalabi A, Hardiman O, Kiernan MC, Chio A, Rix-Brooks B, van den Berg LH. Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol. 2016;15(11):1182–94.
Chio A, Calvo A, Moglia C, Mazzini L, Mora G, PARALS Study Group. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82(7):740–6.
Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102–8.
Hamano T, Mutoh T, Hirayama M, Kuriyama M. [Benign monomelic amyotrophy]. Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):388–91.
Delerue O, Hurtevent JF, Destee A. [Benign, monomelic juvenile amyotrophy of a hand (Hirayama type): a new case report]. Acta Neurol Belg. 1990;90(2):82–6.
Drozdowski W, Baniukiewicz E, Lewonowska M. [Juvenile monomelic amyotrophy: Hirayama disease]. Neurol Neurochir Pol. 1998;32(4):943–50.
Nalini A, Gourie-Devi M, Thennarasu K, Ramalingaiah AH. Monomelic amyotrophy: clinical profile and natural history of 279 cases seen over 35 years (1976-2010). Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5-6):457–65.
Liewluck T, Saperstein DS. Progressive muscular atrophy. Neurol Clin. 2015;33(4):761–73.
Statland JM, Barohn RJ, Dimachkie MM, Floeter MK, Mitsumoto H. Primary lateral sclerosis. Neurol Clin. 2015;33(4):749–60.
Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet. 2009;10(11):769–82.
Fermin AM, Afzal U, Culebras A. Sleep in neuromuscular diseases. Sleep Med Clin. 2016;11(1):53–64.
Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol. 2000;29(2):141–50.
Santos C, Braghiroli A, Mazzini L, Pratesi R, Oliveira LV, Mora G. Sleep-related breathing disorders in amyotrophic lateral sclerosis. Monaldi Arch Chest Dis. 2003;59(2):160–5.
Horner RL. Pathophysiology of obstructive sleep apnea. J Cardiopulm Rehabil Prev. 2008;28(5):289–98.
Dhand UK, Goyal MK, Sahota PK. Sleep related hypoventilation/hypoxemia due to neuromuscular and chest wall disorders. In: Kushida C, editor. Encyclopedia of sleep. 1st ed: Academic Press; 2012.
Gaig C, Iranzo A. Sleep-disordered breathing in neurodegenerative diseases. Curr Neurol Neurosci Rep. 2012;12(2):205–17.
Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218–26.
Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597–619.
Piper AJ. Nocturnal hypoventilation - identifying & treating syndromes. Indian J Med Res. 2010;131:350–65.
Flenley DC. Sleep in chronic obstructive lung disease. Clin Chest Med. 1985;6(4):651–61.
Labanowski M, Schmidt-Nowara W, Guilleminault C. Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population. Neurology. 1996;47(5):1173–80.
Nicolle MW. Sleep and neuromuscular disease. Semin Neurol. 2009;29(4):429–37.
Romigi A, Liguori C, Placidi F, Albanese M, Izzi F, Uasone E, et al. Sleep disorders in spinal and bulbar muscular atrophy (Kennedy’s disease): a controlled polysomnographic and self-reported questionnaires study. J Neurol. 2014;261(5):889–93.
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22(5):667–89.
Kimura K, Tachibana N, Kimura J, Shibasaki H. Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis. J Neurol Sci. 1999;164(1):37–43.
David WS, Bundlie SR, Mahdavi Z. Polysomnographic studies in amyotrophic lateral sclerosis. J Neurol Sci. 1997;152(Suppl 1):S29–35.
Arnulf I, Similowski T, Salachas F, Garma L, Mehiri S, Attali V, et al. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2000;161(3 Pt 1):849–56.
Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124(Pt 10):2000–13.
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–19.
Lo Coco D, Piccoli F, La Bella V. Restless legs syndrome in patients with amyotrophic lateral sclerosis. Mov Disord. 2010;25(15):2658–61.
Lo Coco D, Puligheddu M, Mattaliano P, Congiu P, Borghero G, Fantini ML, et al. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand. 2017;135(2):219–24.
Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.
Javad Mousavi SA, Zamani B, Shahabi Shahmiri S, Rohani M, Shahidi GA, Mostafapour E, et al. Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival. Iran J Neurol. 2014;13(3):131–7.
Bach JR, Bakshiyev R, Hon A. Noninvasive respiratory management for patients with spinal cord injury and neuromuscular disease. Tanaffos. 2012;11(1):7–11.
Kim SM, Park KS, Nam H, Ahn SW, Kim S, Sung JJ, et al. Capnography for assessing nocturnal hypoventilation and predicting compliance with subsequent noninvasive ventilation in patients with ALS. PLoS One. 2011;6(3):e17893.
Stefanutti D, Benoist MR, Scheinmann P, Chaussain M, Fitting JW. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1507–11.
Miller JM, Moxham J, Green M. The maximal sniff in the assessment of diaphragm function in man. Clin Sci (Lond). 1985;69(1):91–6.
Carratu P, Cassano A, Gadaleta F, Tedone M, Dongiovanni S, Fanfulla F, et al. Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results. Amyotroph Lateral Scler. 2011;12(6):458–63.
Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults–an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35(8):1039–62.
Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation–a consensus conference report. Chest. 1999;116(2):521–34.
Boentert M, Brenscheidt I, Glatz C, Young P. Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis. J Neurol. 2015;262(9):2073–82.
Gonzalez-Bermejo J, Morelot-Panzini C, Salachas F, Redolfi S, Straus C, Becquemin MH, et al. Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13(1):44–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Yerram, S., Bollu, P.C., Sahota, P. (2018). Sleep Issues in Motor Neuron Diseases. In: Govindarajan, R., Bollu, P. (eds) Sleep Issues in Neuromuscular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-73068-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-73068-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73067-7
Online ISBN: 978-3-319-73068-4
eBook Packages: MedicineMedicine (R0)